GH1 and cancer: At this point, however, based upon findings in other GH-related long-lived mutants (Ikeno et al., 2003; Vergara et al., 2004; Ikeno et al., 2009), we suspect that reduced incidence and/or delayed onset of cancer may have contributed to extended longevity of GHRH-KO mice.